Navigation Links
Statins Don't Cut Cancer Risk
Date:2/5/2009

Animal study found 2 popular cholesterol-lowering drugs had little effect on tumors

THURSDAY, Feb. 5 (HealthDay News) -- Statins have clearly proven their mettle against heart disease, but the cholesterol-lowering drugs don't appear to possess cancer-fighting powers, a new animal study shows.

"We certainly didn't see any positive effects," said Ronald Lubet, program director in the division of cancer prevention at the National Cancer Institute. He led the study using mice and rats, which was published in the February issue of Cancer Prevention Research.

Lubet and his colleagues studied the effects of two popular cholesterol-lowering drugs, atorvastatin (Lipitor) and lovastatin (Mevacor), in warding off breast cancer. "The initial dose was about twice as high as what a person would typically use," he said. "The second dose was even higher."

Some researchers were hoping statins might have a double-edged effect, reducing heart disease risk as well as guarding against cancer. For instance, one recent study found that men who took statins had lower blood levels of prostate-specific antigen (PSA), a biomarker for prostate cancer risk.

And in a report published in the Journal of the National Cancer Institute in 2006, researchers found statins were associated with lower breast cancer incidence among women in the large-scale Women's Health Initiative trial and called for further study of the possible link.

Exactly how statins might fight cancer isn't certain. But Lubet's group did not see any such potential with the statins it tested.

The researchers gave Lipitor at a dose of either 125 milligrams or 500 milligrams per kilogram of body weight to the animals, mixing it into their diet, but it showed no anti-cancer effect.

They also compared the use of the anti-cancer drugs tamoxifen and bexarotene by themselves and with atorvastatin. The anti-cancer drugs reduced breast tumors in the animals, but adding the statin did not improve the effect.

The researchers also gave lovastatin at 100- and 500-milligram per kilogram of body weight to the animals but again did not uncover any cancer-fighting effects.

"In these two relatively standard animal models, [the statins] were not effective in preventing the development of tumors," Lubet said.

Lubet's group conducted the study, because the data to date has been mixed, with some studies showing the statins helped prevent cancer but others not. They wanted to see if clinical trials with humans, which are expensive, were warranted.

"To go to a large-scale trial, this [study] would not support it," Lubet said.

The new finding reflects the evidence to date from human studies, said Eric J. Jacobs, strategic director of pharmacoepidemiology at the American Cancer Society in Atlanta.

"The totality of the evidence from human studies also indicates that statins are unlikely to reduce the risk of breast cancer," Jacobs said. "While statins are proven effective in saving lives from heart disease, they should not be used in the hope of reducing the risk of cancer."

What would help?

"Maintaining a healthy weight will reduce a woman's risk of developing breast cancer, as well as many other serious health problems," he said.

More information

To learn more about statins, visit the American Heart Association.



SOURCES: Eric Jacobs, Ph.D., American Cancer Society, Atlanta; Ronald Lubet, Ph.D., program director, division of cancer prevention, National Cancer Institute, Rockville, Md.; February 2009, Cancer Prevention Research; Oct. 28, 2008, and May 17, 2006, Journal of the National Cancer Institute


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Got High Cholesterol? Statins Are Not the Only Answer, Says Natural Solutions Magazine
2. Millions More Americans Might Be Placed on Statins
3. Statins Help Prevent Delirium After Heart Surgery
4. WomenHeart Urges Women to Talk With Doctors About New Study Showing Statins Prevent Heart Attacks, Deaths
5. Statins Lower Blood Marker for Prostate Cancer
6. Statins Reduced Death Risk From Pneumonia
7. Statins Lower Risk of Clots in Cancer Patients
8. Statins show promise for blood clot prevention
9. Statins Show Promise for Blood Clot Prevention
10. Statins Help Obese People After Bypass Surgery
11. Research Shows Why Statins Dont Work for Everyone
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statins Don't Cut Cancer Risk
(Date:9/21/2017)... ... September 21, 2017 , ... Preora Diagnostics Inc. ... screening tests, has received two prestigious recognitions that acknowledge the promise of its ... Preora has been named a Top 100 Finalist for the 16th annual ...
(Date:9/21/2017)... ... September 21, 2017 , ... FlipBelt, the fitness brand ... to detail to the athletic wear market with the launch of their FlipBelt Crops. ... have their essentials securely at their fingertips while at the gym, on the trail, ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... Month, Lewis and Clark College Emeritus Professor of Education Gregory A. Smith examines ... of Asleep at the Switch: Schoolhouse Commercialism, Privacy, and the Failure of ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... Coating System for clients that rely on safety and cleanliness. This unique flooring ... , Silver has been used for centuries for its antimicrobial properties. Unlike antibiotics, ...
(Date:9/20/2017)... ... ... Doctors on Liens has added the medical group Bones and Spine Surgery, ... personal injury lien basis. Founded by Dr. Wayne Cheng, MD and Dr. Gordon Yee, ... orthopedic injuries to patients in the Inland Empire. , Bones and Spines Surgery Inc ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... , Sept. 5, 2017  Just 18 months ... Insight is pleased to announce the appointment of three ... Tammy Wynne , Dominic Jones-Phillips and ... industry. Tammy ... team of market access writers. She has over ten ...
(Date:9/1/2017)... 1, 2017  Bayer will present the latest research from ... Medical Oncology (ESMO) 2017 Congress, September 8-12 in ... preclinical and clinical data on Bayer,s marketed portfolio and late-stage ... "We value the ... cancer research at ESMO," said Carsten Brunn , Head ...
(Date:8/28/2017)... Holdings, Inc. (NYSE: HRC), will present at the Morgan Stanley ... New York . John Greisch , Hill-Rom,s ... 11:05 a.m. Eastern Time. The live audio ... replay will be available one hour after the conclusion of ... About Hill-Rom Holdings, Inc. Hill-Rom ...
Breaking Medicine Technology: